JS1:9 LIMITED

Executive Summary

JS1:9 LIMITED demonstrates a healthy and improving financial position characterized by positive working capital and growing shareholder funds. The company benefits from strong owner control and good compliance discipline but should monitor key person risks and prepare for potential growth beyond micro-entity status. Continued prudent financial management will support sustained business health.

JS1:9 LIMITED - Analysis Report

Company Number: 13477364

Analysis Date: 2025-07-29 14:24 UTC

Financial Health Assessment for JS1:9 LIMITED

---

1. Financial Health Score: B

Explanation:
JS1:9 LIMITED displays a solid and improving financial position for a micro-entity operating in the specialist medical practice sector. The company shows increasing net current assets and shareholders’ funds year on year, indicating growth and strengthening liquidity. The absence of overdue filings and a single employee structure suggest streamlined operations. However, as a micro-entity, the scale is modest, and vigilance is warranted to sustain momentum.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£12,642	Healthy increase from prior years, indicating growing cash, receivables, or short-term assets.
Current Liabilities	£9,220	Moderate increase but well covered by current assets; no immediate liquidity stress.
Net Current Assets	£3,422	Positive working capital shows ability to meet short-term obligations comfortably.
Net Assets	£3,422	Positive net worth reflects accumulated retained earnings or capital injection; a sign of strength.
Shareholders’ Funds	£3,422	Equity entirely owned by Dr. Georgy Pius, indicating strong owner commitment and control.
Employee Count	1	Very lean staffing consistent with micro-entity status; operational risk if key person is unavailable.
Filing Status	Up to date	No overdue accounts or confirmation statements, indicating good compliance discipline.

---

3. Diagnosis: What the Financial Data Reveals

JS1:9 LIMITED’s financial “vital signs” show a business with healthy cash flow management and a stable capital base for its size. The growth in current assets from £6,752 in 2023 to £12,642 in 2024, coupled with only a moderate increase in current liabilities, is a strong symptom of improving liquidity and operational health. The net current assets have grown significantly, indicating the company is increasingly able to cover short-term debts, a hallmark of financial wellness.

The modest net asset base of £3,422, while small, is positive and growing annually, reflecting reinvestment or capital contributions by the sole owner, Dr. Georgy Pius. This equity cushion provides a buffer against operational shocks.

The company’s micro-entity status means it operates at a small scale with limited complexity, which typically reduces financial and regulatory risk. The single employee model and owner control can be a double-edged sword: it ensures quick decision-making but also means the business is highly dependent on one individual.

Overall, the accounts show no “symptoms of distress” such as negative working capital, declining equity, or overdue filings. The business appears stable and well-managed for its current scale.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Maintain Cash Flow Vigilance: Continue to monitor cash inflows and outflows closely to sustain the positive working capital trend. Consider building a cash reserve to cushion any unforeseen expenses or downturns.

• Diversify Operational Capacity: Given the single-employee structure, consider contingency planning for key person risk, possibly through part-time support or outsourcing administrative tasks.

• Plan for Growth: As the business grows, evaluate the potential need to transition from micro to small entity status. This will require enhanced financial controls and possibly formal audits.

• Leverage Owner’s Expertise: Dr. Georgy Pius’s dual role as director and specialist professional is a strength. Ensure governance structures are in place to manage potential conflicts between clinical and business decisions.

• Regular Financial Reviews: Conduct quarterly financial health checks to identify any emerging symptoms of financial stress early.

---